CoChat
Sign Up
Cited by 643

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Cholesterol gallstone disease

Portincasa, Piero, Moschetta, Antonio, Palasciano, Giuseppe·2006·The Lancet
DOI 10.1016/s0140-6736(06)69044-2
Open this paper in CoChat — free account

Abstract

With a prevalence of 10-15% in adults in Europe and the USA, gallstones are the most common digestive disease needing admission to hospital in the West. The interplay between interprandial and postprandial physiological responses to endogenous and dietary lipids underscores the importance of coordinated hepatobiliary and gastrointestinal functions to prevent crystallisation and precipitation of excess biliary cholesterol. Indeed, identifying the metabolic and transcriptional pathways that drive the regulation of biliary lipid secretion has been a major achievement in the field. We highlight scientific advances in protein and gene regulation of cholesterol absorption, synthesis, and catabolism, and biliary lipid secretion with respect to the pathogenesis of cholesterol gallstone disease. We discuss the physical-chemical mechanisms of gallstone formation in bile and the active role of the gallbladder and the intestine. We also discuss gaps in our knowledge of the pathogenesis of gallstone formation and the potential for gene targeting in therapy.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(06)69044-2

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 136

  1. Gordon-Taylor, 1937, On gallstones and their sufferers, Br J Surg, 25, 241, 10.1002/bjs.1800259802 · DOI
  2. Shehadi, 1979, The biliary system through the ages, Int Surg, 64, 63
  3. Everhart, 1999, Prevalence and ethnic differences in gallbladder disease in the United States, Gastroenterology, 117, 632, 10.1016/S0016-5085(99)70456-7 · DOI
  4. Sandler, 2002, The burden of selected digestive diseases in the United States, Gastroenterology, 122, 1500, 10.1053/gast.2002.32978 · DOI · Paper page
  5. 1993, Am J Surg, 165, 390, 10.1016/S0002-9610(05)80929-8 · DOI
  6. Langenbuch, 1882, Ein fall von extirpation der gallenblase wegen chronischer cholelithiasis. Heilung, Berlin Klin Wochenschr, 19, 725
  7. Schiff, 1873, Il coleinato di soda nella cura dei calcoli biliari, L'Imparziale, 13, 97
  8. Dabney, 1876, The use of choleate of soda to prevent the formation of gallstones, Am J Med Sci, 71, 410, 10.1097/00000441-187604000-00011 · DOI
  9. Rewbridge, 1937, The disappearance of gallstone shadows following the prolonged admnistration of bile acids, Surgery, 1, 395
  10. Danzinger, 1972, Dissolution of cholesterol gallstones by chenodeoxycholic acid, N Engl J Med, 286, 1, 10.1056/NEJM197201062860101 · DOI
  11. Makino, 1975, [Dissolution of cholesterol gallstones by long-term administration of ursodeoxycholic acid], Nippon Shokakibyo Gakkai Zasshi, 72, 690
  12. Sauerbruch, 1986, Fragmentation of gallstones by extracorporeal shock waves, N Engl J Med, 314, 818, 10.1056/NEJM198603273141304 · DOI
  13. Villanova, 1989, Gallstone recurrence after successful oral bile acid treatment: a 12 year follow-up study and evaluation of long term postdissolution treatment, Gastroenterology, 97, 726, 10.1016/0016-5085(89)90644-6 · DOI
  14. Sackmann, 1994, Gallstone recurrence after shock-wave therapy, Gastroenterology, 106, 225, 10.1016/S0016-5085(94)95581-6 · DOI
  15. Mouret, 1990, [Celioscopic surgery. Evolution or revolution?], Chirurgie, 116, 829
  16. Diehl, 1991, Epidemiology and natural history of gallstone disease, Gastroenterol Clin North Am, 20, 1, 10.1016/S0889-8553(21)00531-8 · DOI
  17. Hofmann, 1993, Pathogenesis and treatment of gallstones, N Engl J Med, 328, 1854, 10.1056/NEJM199306243282517 · DOI
  18. LaMont, 1992, Cholesterol gallstone formation. 2. Pathobiology and pathomechanics, Prog Liver Dis, 10, 165
  19. Shieh, 1977, Crystal structure of anhydrous cholesterol, Nature, 267, 287, 10.1038/267287a0 · DOI
  20. Konikoff, 1992, Filamentous, helical, and tubular microstructures during cholesterol crystallization from bile. Evidence that cholesterol does not nucleate classic monohydrate plates, J Clin Invest, 90, 1155, 10.1172/JCI115935 · DOI
  21. Craven, 1976, Crystal structure of cholesterol monohydrate, Nature, 260, 727, 10.1038/260727a0 · DOI
  22. Portincasa, 1996, Behavior of various cholesterol crystals in bile from patients with gallstones, Hepatology, 23, 738, 10.1002/hep.510230414 · DOI
  23. Carey, 1978, Critical tables for calculating the cholesterol saturation of native bile, J Lipid Res, 19, 945, 10.1016/S0022-2275(20)40677-7 · DOI
  24. Admirand, 1968, The physicochemical basis of cholesterol gallstone formation in man, J Clin Invest, 47, 1043, 10.1172/JCI105794 · DOI
  25. Wang, 1996, Characterization of crystallization pathways during cholesterol precipitation from human gallbladder biles: identical pathways to corresponding model biles with three predominating sequences, J Lipid Res, 37, 2539, 10.1016/S0022-2275(20)37458-7 · DOI
  26. Wang, 1996, J Lipid Res, 37, 606, 10.1016/S0022-2275(20)37603-3 · DOI
  27. Konikoff, 2000, Microstructural evolution of lipid aggregates in nucleating model and human biles visualized by cryogenic transmission electron microscopy, Hepatology, 31, 261, 10.1002/hep.510310202 · DOI
  28. Ko, 1999, Biliary sludge, Ann Intern Med, 130, 301, 10.7326/0003-4819-130-4-199902160-00016 · DOI
  29. Apstein, 1996, Pathogenesis of cholesterol gallstones: a parsimonious hypothesis, Eur J Clin Invest, 26, 343, 10.1046/j.1365-2362.1996.148287.x · DOI
  30. Holzbach, 1973, Cholesterol solubility in bile. Evidence that supersaturated bile is frequent in healthy man, J Clin Invest, 52, 1467, 10.1172/JCI107321 · DOI
  31. Jirsa, 2001, Role of biliary proteins and non-protein factors in kinetics of cholesterol crystallisation and gallstone growth, Front Biosci, 6, 154, 10.2741/Jirsa · DOI
  32. Portincasa, 1994, Gallbladder motor function in gallstone patients: sonographic and in vitro studies on the role of gallstones, smooth muscle function and gallbladder wall inflammation, J Hepatol, 21, 430, 10.1016/S0168-8278(05)80324-1 · DOI
  33. Portincasa, 2003, Water handling and aquaporins in bile formation: recent advances and research trends, J Hepatol, 39, 864, 10.1016/S0168-8278(03)00294-0 · DOI
  34. Crawford, 1997, Hepatic secretion of phospholipid vesicles in the mouse critically depends on mdr2 or MDR3 P-glycoprotein expression. Visualization by electron microscopy, J Clin Invest, 100, 2562, 10.1172/JCI119799 · DOI
  35. Hofmann, 1999, The continuing importance of bile acids in liver and intestinal disease, Arch Intern Med, 159, 2647, 10.1001/archinte.159.22.2647 · DOI
  36. Gerloff, 1998, The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver, J Biol Chem, 273, 10046, 10.1074/jbc.273.16.10046 · DOI
  37. Smit, 1993, Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease, Cell, 75, 451, 10.1016/0092-8674(93)90380-9 · DOI
  38. Yu, 2002, Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion, Proc Natl Acad Sci USA, 99, 16237, 10.1073/pnas.252582399 · DOI
  39. Makishima, 1999, Identification of a nuclear receptor for bile acids, Science, 284, 1362, 10.1126/science.284.5418.1362 · DOI · Paper page
  40. Parks, 1999, Bile acids: natural ligands for an orphan nuclear receptor, Science, 284, 1365, 10.1126/science.284.5418.1365 · DOI · Paper page
  41. Janowski, 1996, An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha, Nature, 383, 728, 10.1038/383728a0 · DOI · Paper page
  42. Zhang, 2001, Key regulatory oxysterols in liver: analysis as delta4-3-ketone derivatives by HPLC and response to physiological perturbations, J Lipid Res, 42, 649, 10.1016/S0022-2275(20)31174-3 · DOI
  43. Ananthanarayanan, 2001, Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor, J Biol Chem, 276, 28857, 10.1074/jbc.M011610200 · DOI
  44. Huang, 2003, Farnesoid X-receptor activates transcription of the phospholipid pump MDR3, J Biol Chem, 278, 51085, 10.1074/jbc.M308321200 · DOI
  45. Repa, 2002, Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta, J Biol Chem, 277, 18793, 10.1074/jbc.M109927200 · DOI
  46. Moschetta, 2004, Prevention of cholesterol gallstone disease by FXR agonists in a mouse model, Nat Med, 10, 1352, 10.1038/nm1138 · DOI
  47. Wang, 2004, Overexpression of liver X receptor α (LXRα) enhance cholesterol (Ch) cholelithogenesis in gallstone-resistant AKR mice, Gastroenterology, 126, 15
  48. Khanuja, 1995, Lith1, a major gene affecting cholesterol gallstone formation among inbred strains of mice, Proc Natl Acad Sci USA, 92, 7729, 10.1073/pnas.92.17.7729 · DOI
  49. Paigen, 2000, Quantitative trait loci mapping for cholesterol gallstones in AKR/J and C57L/J strains of mice, Physiol Genomics, 4, 59, 10.1152/physiolgenomics.2000.4.1.59 · DOI
  50. Hillebrandt, 2003, Mouse models for genetic dissection of polygenic gastrointestinal diseases, Eur J Clin Invest, 33, 155, 10.1046/j.1365-2362.2003.01089.x · DOI
  51. Wang, 2004, Genetic analysis of cholesterol gallstone formation: searching for Lith (gallstone) genes, Curr Gastroenterol Rep, 6, 140, 10.1007/s11894-004-0042-1 · DOI
  52. Lammert, 2005, The genetic background of cholesterol gallstone formation: an inventory of human lithogenic genes, Curr Drug Targets Immune Endocr Metabol Disord, 5, 163, 10.2174/1568008054064841 · DOI
  53. Lammert, 2005, Mechanisms of disease: the genetic epidemiology of gallbladder stones, Nat Clin Pract Gastroenterol Hepatol, 2, 423, 10.1038/ncpgasthep0257 · DOI
  54. van Erpecum, 1992, Fasting gallbladder volume, postprandial emptying and cholecystokinin release in gallstone patients and normal subjects, J Hepatol, 14, 194, 10.1016/0168-8278(92)90158-L · DOI
  55. Xiao, 2005, Impaired cytoprotective function of muscle in human gallbladders with cholesterol stones, Am J Physiol Gastrointest Liver Physiol, 288, G525, 10.1152/ajpgi.00261.2004 · DOI
  56. Portincasa, 2004, Smooth muscle function and dysfunction in gallbladder disease, Curr Gastroenterol Rep, 6, 151, 10.1007/s11894-004-0043-0 · DOI
  57. van Erpecum, 2000, Review article: agents affecting gall-bladder motility—role in treatment and prevention of gallstones, Aliment Pharmacol Ther, 14, 66, 10.1046/j.1365-2036.2000.014s2066.x · DOI
  58. Pauletzki, 1996, Gallbladder emptying and gallstone formation: a prospective study on gallstone recurrence, Gastroenterology, 111, 765, 10.1053/gast.1996.v111.pm8780583 · DOI
  59. Portincasa, 1996, Apolipoprotein E4 genotype and gallbladder motility influence speed of gallstone clearance and risk of recurrence after extracorporeal shock-wave lithotripsy, Hepatology, 24, 580
  60. Wang, 2004, Targeted disruption of the murine cholecystokinin-1 receptor promotes intestinal cholesterol absorption and susceptibility to cholesterol cholelithiasis, J Clin Invest, 114, 521, 10.1172/JCI16801 · DOI
  61. Sitzmann, 1990, Cholecystokinin prevents parenteral nutrition induced biliary sludge in humans, Surg Gynecol Obstet, 170, 25
  62. Shoda, 1995, Increase of deoxycholate in supersaturated bile of patients with cholesterol gallstone disease and its correlation with de novo syntheses of cholesterol and bile acids in liver, gallbladder emptying, and small intestinal transit, Hepatology, 21, 1291
  63. Heaton, 1993, An explanation for gallstones in normal-weight women: slow intestinal transit, Lancet, 341, 8, 10.1016/0140-6736(93)92479-D · DOI
  64. van Erpecum, 1999, Gallstones: an intestinal disease?, Gut, 44, 435, 10.1136/gut.44.3.435 · DOI
  65. Thomas, 2000, Mechanism for the transit-induced increase in colonic deoxycholic acid formation in cholesterol cholelithiasis, Gastroenterology, 119, 806, 10.1053/gast.2000.16495 · DOI
  66. Thomas, 2005, Octreotide induced prolongation of colonic transit increases faecal anaerobic bacteria, bile acid metabolising enzymes, and serum deoxycholic acid in patients with acromegaly, Gut, 54, 630, 10.1136/gut.2003.028431 · DOI
  67. Berr, 1996, 7 alpha-dehydroxylating bacteria enhance deoxycholic acid input and cholesterol saturation of bile in patients with gallstones, Gastroenterology, 111, 1611, 10.1016/S0016-5085(96)70024-0 · DOI
  68. Van Erpecum, 2001, Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: soluble pronucleating proteins in gallbladder and hepatic biles, J Hepatol, 35, 444, 10.1016/S0168-8278(01)00173-8 · DOI
  69. DiMagno, 1979, Relationships among canine fasting pancreatic and biliary secretions, pancreatic duct pressure, and duodenal phase III motor activity—Boldyreff revisited, Dig Dis Sci, 24, 689, 10.1007/BF01314466 · DOI
  70. Stolk, 1993, Motor cycles with phase III in antrum are associated with high motilin levels and prolonged gallbladder emptying, Am J Physiol, 264, 596
  71. Stolk, 2001, Interdigestive gallbladder emptying, antroduodenal motility, and motilin release patterns are altered in cholesterol gallstone patients, Dig Dis Sci, 46, 1328, 10.1023/A:1010635901414 · DOI
  72. Attili, 1998, Diet and gallstones in Italy: the cross-sectional MICOL results, Hepatology, 27, 1492, 10.1002/hep.510270605 · DOI · Paper page
  73. Wang, 2005, High cholesterol absorption efficiency and rapid biliary secretion of chylomicron remnant cholesterol enhance cholelithogenesis in gallstone-susceptible mice, Biochim Biophys Acta, 1733, 90, 10.1016/j.bbalip.2004.12.005 · DOI
  74. Denbesten, 1973, The effect of dietary cholesterol on the composition of human bile, Surgery, 73, 266
  75. Lee, 1985, Effect of dietary cholesterol on biliary lipids in patients with gallstones and normal subjects, Am J Clin Nutr, 42, 414, 10.1093/ajcn/42.3.414 · DOI
  76. Nervi, 1989, Influence of legume intake on biliary lipids and cholesterol saturation in young Chilean men. Identification of a dietary risk factor for cholesterol gallstone formation in a highly prevalent area, Gastroenterology, 96, 825, 10.1016/S0016-5085(89)80083-6 · DOI
  77. Andersen, 1979, The effect of cholesterol feeding on bile acid kinetics and biliary lipids in normolipidemic and hypertriglyceridemic subjects, J Lipid Res, 20, 1020, 10.1016/S0022-2275(20)40004-5 · DOI
  78. Maurer, 2006, Helicobacter pylori and cholesterol gallstone formation in C57L/J mice: a prospective study, Am J Physiol Gastrointest Liver Physiol, 290, G175, 10.1152/ajpgi.00272.2005 · DOI
  79. Maurer, 2005, Identification of cholelithogenic enterohepatic Helicobacter species and their role in murine cholesterol gallstone formation, Gastroenterology, 128, 1023, 10.1053/j.gastro.2005.01.008 · DOI
  80. Fox, 1998, Hepatic Helicobacter species identified in bile and gallbladder tissue from Chileans with chronic cholecystitis, Gastroenterology, 114, 755, 10.1016/S0016-5085(98)70589-X · DOI
  81. Pereira, 2003, Bile composition in inflammatory bowel disease: ileal disease and colectomy, but not colitis, induce lithogenic bile, Aliment Pharmacol Ther, 17, 923, 10.1046/j.1365-2036.2003.01529.x · DOI
  82. Brink, 1999, Enterohepatic cycling of bilirubin: a putative mechanism for pigment gallstone formation in ileal Crohn's disease, Gastroenterology, 116, 1420, 10.1016/S0016-5085(99)70507-X · DOI
  83. Heaton, 1991, Symptomatic and silent gall stones in the community, Gut, 32, 316, 10.1136/gut.32.3.316 · DOI
  84. Sampliner, 1970, Gallbladder disease in Pima Indians: demonstration of high prevalence and early onset by cholecystography, N Engl J Med, 283, 1358, 10.1056/NEJM197012172832502 · DOI
  85. Everhart, 2002, Prevalence of gallbladder disease in American Indian populations: findings from the Strong Heart Study, Hepatology, 35, 1507, 10.1053/jhep.2002.33336 · DOI
  86. Miquel, 1998, Genetic epidemiology of cholesterol cholelithiasis among Chilean Hispanics, Amerindians, and Maoris, Gastroenterology, 115, 937, 10.1016/S0016-5085(98)70266-5 · DOI
  87. Attili, 1995, Epidemiology of gallstone disease in Italy: prevalence data of the Multicenter Italian Study on Cholelithiasis (MICOL), Am J Epidemiol, 141, 158, 10.1093/oxfordjournals.aje.a117403 · DOI
  88. Palasciano, 1989, Gallstone prevalence and gallbladder volume in children and adolescents: an epidemiological ultrasonographic survey and relationship to body mass index, Am J Gastroenterol, 84, 1378
  89. Shaffer, 2005, Epidemiology and risk factors for gallstone disease: has the paradigm changed in the 21st century?, Curr Gastroenterol Rep, 7, 132, 10.1007/s11894-005-0051-8 · DOI
  90. Gilat, 1983, An increased familial frequency of gallstones, Gastroenterology, 84, 242, 10.1016/S0016-5085(83)80118-8 · DOI
  91. Sarin, 1995, High familial prevalence of gallstones in the first-degree relatives of gallstone patients, Hepatology, 22, 138
  92. Rosmorduc, 2001, MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis, Gastroenterology, 120, 1459, 10.1053/gast.2001.23947 · DOI
  93. Rosmorduc, 2003, ABCB4 gene mutation-associated cholelithiasis in adults, Gastroenterology, 125, 452, 10.1016/S0016-5085(03)00898-9 · DOI · Paper page
  94. 1988, The Rome Group for Epidemiology and Prevention of Cholelithiasis (GREPCO), Hepatology, 8, 907
  95. Bennion, 1978, Risk factors for the development of cholelithiasis in man (second of two parts), N Engl J Med, 299, 1221, 10.1056/NEJM197811302992205 · DOI
  96. Liddle, 1989, Gallstone formation during weight-reduction dieting, Arch Intern Med, 149, 1750, 10.1001/archinte.1989.00390080036009 · DOI · Paper page
  97. Attili, 1997, Factors associated with gallstone disease in the MICOL experience. Multicenter Italian Study on Epidemiology of Cholelithiasis, Hepatology, 26, 809, 10.1002/hep.510260401 · DOI
  98. Cuevas, 2004, Diet as a risk factor for cholesterol gallstone disease, J Am Coll Nutr, 23, 187, 10.1080/07315724.2004.10719360 · DOI
  99. Eckel, 2005, The metabolic syndrome, Lancet, 365, 1415, 10.1016/S0140-6736(05)66378-7 · DOI
  100. Grundy, 2004, Cholesterol gallstones: a fellow traveler with metabolic syndrome?, Am J Clin Nutr, 80, 1, 10.1093/ajcn/80.1.1 · DOI
  101. Honda, 1993, Hepatic cholesterol and bile acid synthesis in Japanese patients with cholesterol gallstones, Gastroenterol Jpn, 28, 406, 10.1007/BF02776986 · DOI
  102. Tsunoda, 2004, Prevalence of cholesterol gallstones positively correlates with per capita daily calorie intake, Hepatogastroenterology, 51, 1271
  103. Johnston, 1993, Pathogenesis and treatment of gallstones, N Engl J Med, 328, 412, 10.1056/NEJM199302113280608 · DOI
  104. Caroli-Bosc, 1998, Cholelithiasis and dietary risk factors: an epidemiologic investigation in Vidauban, Southeast France. General Practitioner's Group of Vidauban, Dig Dis Sci, 43, 2131, 10.1023/A:1018879819301 · DOI
  105. Maclure, 1989, Weight, diet, and the risk of symptomatic gallstones in middle-aged women, N Engl J Med, 321, 563, 10.1056/NEJM198908313210902 · DOI · Paper page
  106. Tsai, 2004, The effect of long-term intake of cis unsaturated fats on the risk for gallstone disease in men: a prospective cohort study, Ann Intern Med, 141, 514, 10.7326/0003-4819-141-7-200410050-00007 · DOI · Paper page
  107. Scragg, 1984, Diet, alcohol, and relative weight in gall stone disease: a case-control study, BMJ (Clin Res Ed), 288, 1113, 10.1136/bmj.288.6424.1113 · DOI
  108. Gibney, 1990, Asymptomatic gallstones, Br J Surg, 77, 368, 10.1002/bjs.1800770405 · DOI
  109. Friedman, 1993, Natural history of asymptomatic and symptomatic gallstones, Am J Surg, 165, 399, 10.1016/S0002-9610(05)80930-4 · DOI
  110. Diehl, 1990, Clinical evaluation for gallstone disease: usefulness of symptoms and signs in diagnosis, Am J Med, 89, 29, 10.1016/0002-9343(90)90094-T · DOI
  111. Tomida, 1999, Long-term ursodeoxycholic acid therapy is associated with reduced risk of biliary pain and acute cholecystitis in patients with gallbladder stones: a cohort analysis, Hepatology, 30, 6, 10.1002/hep.510300108 · DOI
  112. Russo, 2004, Digestive and liver diseases statistics, 2004, Gastroenterology, 126, 1448, 10.1053/j.gastro.2004.01.025 · DOI
  113. Randi, 2006, Gallbladder cancer worldwide: Geographical distribution and risk factors, Int J Cancer, 118, 1591, 10.1002/ijc.21683 · DOI
  114. Leopold, 1976, Gray scale ultrasonic cholecystography: a comparison with conventional radiographic techniques, Radiology, 121, 445, 10.1148/121.2.445 · DOI
  115. Everson, 1980, A critical evaluation of real-time ultrasonography for the study of gallbladder volume and contraction, Gastroenterology, 79, 40, 10.1016/0016-5085(80)90072-4 · DOI
  116. Portincasa, 2003, Measurements of gallbladder motor function by ultrasonography: towards standardization, Dig Liver Dis, 35, S56, 10.1016/S1590-8658(03)00096-3 · DOI
  117. Kalimi, 2001, Diagnosis of acute cholecystitis: sensitivity of sonography, cholescintigraphy, and combined sonography-cholescintigraphy, J Am Coll Surg, 193, 609, 10.1016/S1072-7515(01)01092-4 · DOI
  118. Sivak, 1989, Endoscopic management of bile duct stones, Am J Surg, 158, 228, 10.1016/0002-9610(89)90256-0 · DOI
  119. 2002, NIH Consens State Sci Statements, 19, 1
  120. Tait, 1995, The treatment of gall stones, BMJ, 311, 99, 10.1136/bmj.311.6997.99 · DOI
  121. Pokorny, 1984, Cholelithiasis and cholecystitis in childhood, Am J Surg, 148, 742, 10.1016/0002-9610(84)90428-8 · DOI
  122. Amaral, 1985, Gallbladder disease in the morbidly obese, Am J Surg, 149, 551, 10.1016/S0002-9610(85)80055-6 · DOI · Paper page
  123. Lowenfels, 1989, Gallstone growth, size, and risk of gallbladder cancer: an interracial study, Int J Epidemiol, 18, 50, 10.1093/ije/18.1.50 · DOI
  124. Ashur, 1978, Calcified ballbladder (porcelain gallbladder), Arch Surg, 113, 594, 10.1001/archsurg.1978.01370170056010 · DOI
  125. Lowenfels, 1985, Gallstones and risk of gallbladder cancer, J Natl Cancer Inst, 75, 77
  126. Venneman, 2005, Small gallstones, preserved gallbladder motility, and fast crystallization are associated with pancreatitis, Hepatology, 41, 738, 10.1002/hep.20616 · DOI
  127. Lee, 1992, Biliary sludge as a cause of acute pancreatitis, N Engl J Med, 326, 589, 10.1056/NEJM199202273260902 · DOI
  128. Ros, 1991, Occult microlithiasis in ‘idiopathic’ acute pancreatitis: prevention of relapses by cholecystectomy or ursodeoxycholic acid therapy, Gastroenterology, 101, 1701, 10.1016/0016-5085(91)90410-M · DOI
  129. Goldacre, 2005, Cancer after cholecystectomy: record-linkage cohort study, Br J Cancer, 92, 1307, 10.1038/sj.bjc.6602392 · DOI
  130. Hellstern, 1998, Dissolution of gallbladder stones with methyl tert-butyl ether and stone recurrence: a European survey, Dig Dis Sci, 43, 911, 10.1023/A:1018811409538 · DOI
  131. Allen, 1985, Rapid dissolution of gallstones by methyl tert-butyl ether. Preliminary observations, N Engl J Med, 312, 217, 10.1056/NEJM198501243120406 · DOI
  132. Paumgartner, 2005, Extracorporeal shock wave lithotripsy of gallstones: 20th anniversary of the first treatment, Eur J Gastroenterol Hepatol, 17, 525, 10.1097/00042737-200505000-00009 · DOI
  133. Paumgartner, 1994, Ursodeoxycholic acid treatment of cholesterol gallstone disease, Scand J Gastroenterol Suppl, 204, 27, 10.3109/00365529409103622 · DOI
  134. Sugerman, 1995, A multicenter, placebo-controlled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric—bypass-induced rapid weight loss, Am J Surg, 169, 91, 10.1016/S0002-9610(99)80115-9 · DOI · Paper page
  135. Venneman, 2006, Ursodeoxycholic acid exerts no beneficial effect in patients with symptomatic gallstones awaiting cholecystectomy, Hepatology, 43, 127, 10.1002/hep.21182 · DOI
  136. Moschetta, 2001, Cholesterol crystallization in model biles. Effects of bile salt and phospholipid species composition, J Lipid Res, 42, 1273, 10.1016/S0022-2275(20)31578-9 · DOI

Cited by

Sorted by citations

Metadata

Authors
Portincasa, P., Moschetta, A., & Palasciano, G.
Venue
The Lancet
Publisher
Elsevier BV
Published
2006-07
Volume
368
Issue
9531
Pages
230-239
ISSN
0140-6736
DOI
10.1016/s0140-6736(06)69044-2
Cited by
643
References
4
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review